Nuclear Medicine Europe
Activity Report 2025 - part 1
First Half-Year in Review
Following the member survey conducted earlier this year, many of you expressed a wish for more regular updates on our progress and activities. In response, we have prepared this Mid-Year Activity Report.
A second edition will be published early 2026, covering the association’s activities in the second half of the year, along with introductions of new members, highlights from networking events, and updates on Working Group initiatives.
If you want to read the previous activity reports, follow this link.
Word of the President
Dear Colleagues,
We have appreciated your interest in being more frequently informed about our activities, and it is with pleasure that we send you this activity report covering the first part of the year 2025.
Despite the difficulties caused by the current geopolitical situation and its repercussions on nuclear medicine and on our industry, we wanted to stay positive and move forward with projects and initiatives involving third parties. You will find them summarised below.
We would like to once again thank you for your support during the last two general assemblies, proof that our efforts meet your expectations in the benefit of our discipline and of the patients.
As required by our regulations, my colleagues and I are currently working on drafting the 3-Year Management Plan, which will be submitted to you in the coming weeks and for which any suggestions from you will be most welcome.
As every year, we will be present at the EANM in October, where we hope to see many of you at our booth 127, as well as at our get-together reserved for our community, for which you will soon receive an invitation.
Without wishing to sound philosophical, I am firmly convinced that nuclear medicine, whose importance has continued to grow in recent years, both in diagnostics and in therapy, is despite economic challenges, entering a significant phase of development. It is only by joining our forces that we will become an indispensable and fully recognized discipline across Europe.
It is precisely this notion of collective action that we put at your disposal, and which we will continue to defend, while ensuring the same consideration for each of you, regardless of your size or resources within our association.
Thank you all for your continued support,
Best regards,
Mart-Jan Blauwhoff, President Nuclear Medicine Europe
Nuclear Medicine Europe and Euratom Supply Agency Strengthen Collaboration on Radioisotope Production in Europe through the European Observatory for the Supply of Radioisotopes
Radioisotopes / European Affairs
Since 2012, the European Observatory for the Supply of Medical Radioisotopes (EU OBS), composed of the Euratom Supply Agency (ESA) and the industry association Nuclear Medicine Europe, have joined forces to ensure effective oversight of radioisotope production across Europe. It is a unique partnership between the European institutions and a related industry association while European Observatories are normally between different EU institutions and eventually NGO’s.
Nuclear Medicine Europe contributes to the EU Observatory with the profound expertise of its members in collaborating with research reactors to deliver safe, reliable, and sustainable supply solutions for European patients and to avoid and mitigate shortages of reactor-based medical isotopes. During the past 13 years this unusual partnership has shown to be a very successful and innovative mode of action.
In January 2025, EU OBS representatives convened Nuclear Medicine Europe to review 13 years of progress, evaluate its strengths and potential areas for improvement, and define a forward-looking strategy—particularly in developing a comprehensive EU-level forecast of radioisotope supply and demand, expanding the scope of the European Observatory also to other new medical radioisotopes.
By the end of this year, Nuclear Medicine Europe, in close cooperation with ESA decision-makers, will be able to present a new long-term action plan. This roadmap will clarify the priorities of our partnership and align operations to achieve optimal efficiency and impact.
A parallel initiative to raise awareness across European countries of the vital role of therapy in nuclear medicine
Therapy / Working Groups
The importance of therapy in nuclear medicine is widely recognised. It no longer needs to be demonstrated but we observe that it is not equally known, implemented, or communicated across the different EU countries.
This is why, in January 2025, the Nuclear Medicine Europe Therapy Working Group started the initiative to approach the Health Attachés of the European representations to the EU, with the aim of raising their awareness of this discipline so that they can relay the information in their respective countries and share their specific expectations with us.
The initial idea was to organise a conference bringing together health representatives from these representations. However, it became clear that their availability—mainly due to the geopolitical situation of recent months—would not allow them to participate effectively. The Therapy Group therefore decided to transform this project into a “Position Paper,” which is currently in preparation. The Working Group Therapy members meet regularly and work on the progress of this project which will be shared with Nuclear Medicine Europe members in the coming months before distribution to the European representations.
Hygieia Superstar
Successes and developments
Awareness / Communication
The very successful interactive Higieia has been recognised with an Interactive Design Award in the UX and UI Digital Design category of the Indigo Design Award. This distinction highlights the project’s excellence in delivering an intuitive and user-friendly experience, reaffirming its effectiveness as a digital design solution.
In addition, the platform has expanded its accessibility by introducing 8 new languages, ensuring a broader reach and enhanced usability for a diverse global audience.
Satisfaction Survey Highlights Member Priorities
Association
Aware of our responsibility to address our members’ expectations efficiently, both in terms of activities and our role in defending the interests of our industry on the European and international scene, we conducted an in-depth satisfaction survey among all members in February 2025.
The survey confirmed key insights such as :
• A growing improvement in our communication tools, both internally (within Nuclear Medicine Europe) and toward the general public
• A gap in monitoring equipment
• Our strengths in advocating for our industry at multiple levels
• A lack of clarity between our role as a “promoter of nuclear medicine” and our position as the unified voice of the nuclear medicine industry in Europe
• The success of the Regulatory Affairs Group in its approach to the EMA (European Medicines Agency)
• An expectation to significantly improve the representation of RLT and consider it a priority;
• Develop market access and reimbursement for novel PET radiotracers; …
We have carefully noted all these comments and suggestions and are now developing a targeted action plan to address these priorities as effectively as possible.
Two New Working Group Chairs Elected
Communication, and Therapy
Working Groups
Nuclear Medicine Europe is pleased to announce the election of Nick den Hartog and Raphaël Ortiz as new Co-Chairs of the Communications and Therapy Working Groups, respectively. Nick, Marketing Lead at NRG PALLAS, brings strong expertise in branding and communications, having led the “Advancing Nuclear Medicine” initiative. Raphaël, CEO of Telix Pharmaceuticals International, offers over a decade of experience in radiopharmaceuticals, focusing on expanding access to Targeted Radionuclide Therapies. Their leadership will help drive progress in communication and therapy efforts across the organisation. Congratulations and welcome aboard!
Read the press release
Best in Brussels Campaign
Honourable Mention
Promotion / Communication
In the 2025 Best in Brussels Awards for Best EU Public Affairs Campaign, the judges published a list of the Top Ten Honourable Mentions to recognise other outstanding campaigns from the EU public affairs community. Among these, the Nuclear Medicine Europe Protecting Patient Care campaign—raising awareness about the potential lead ban—was highlighted as a notable achievement.
Communicate Efficiently
A YouTube Star in the Nuclear Medicine World
Awareness / Communication
Effective science communication is crucial in making complex topics accessible to diverse audiences. In this interview, we speak with Dr. Paulien Moyaert, a physician-scientist who has successfully leveraged digital media to demystify nuclear medicine. As the creator of a highly successful YouTube channel, she produces concise, engaging videos on a variety of medical topics, using 3D models, dynamic PowerPoint slides, and even real surgical footage.
From explaining intricate medical concepts to combating misconceptions, she shares her approach and experience in making scientific topics clearer and more engaging for professionals and the public alike.
Read the publication : Communicating nuclear medicine to a wider audience
Official Recognition of the Title “EU Affairs Representative”
Association / EU Affairs
We have formally recognised the role of our Vice President, Dr. Konrade von Bremen, as the official representative for European affairs to the EU institutions. This title grants Dr. von Bremen official access to all European representations relevant to our field.
Dr. von Bremen has been working for several years on European projects such as the Europe’s Beating Cancer Plan, ERVI (European Radioisotopes Valley Initiative), SAMIRA, the SIMPLERAD Project, the Critical Medicines Act, and the Reform of the EU Pharmaceutical Legislation. She has also recently begun active participation in the new EU rules on Health Technology Assessment.
SNMMI 2025 - New Orleans
The North American Annual Meeting
Event / Networking
The North American Annual Congress of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) took place in early June in New Orleans, the vibrant city known for its rich jazz heritage and lively culture.
During this activity-packed event, Nuclear Medicine Europe took part in the CORAR 2025 Informal Meeting of Trade Associations, an opportunity to exchange ideas and discuss policy progress with our partners.
On the second day, the Security of Supply Working Group held its update meeting—always a valuable occasion to connect with members who are not frequently present in Europe. This was followed by the Get Together at the Loews Hotel, where around 45 guests enjoyed a friendly networking evening.
The remaining days were dedicated to congress sessions and networking activities. Once again, the Nuclear Medicine Europe booth proved to be the ideal meeting point for companies and members, fostering discussions and collaborations throughout the event.
Development of Our Collaboration with EANM
Association / EANM
On 23 July 2025, a meeting was held with the EANM management (Mr. Henrik Silber) in their Vienna Headquarters, at the initiative of Nuclear Medicine Europe, represented by Konrade von Bremen.
The purpose of this initiative was to strengthen informal exchanges between our two associations, paving the way for essential collaboration for the benefit of our discipline and, ultimately, for patients.
The discussions proved fruitful and encouraging. A draft official partnership agreement is currently being structured and will likely be finalised during the EANM Congress in October. The possibility of organising a joint summit by our two associations, to be considered in the course of 2026, was also discussed.
Annual General Assembly
Prestigious people, in prestigious places
Association / Networking
This year, the association had the pleasure of hosting its annual dinner at the prestigious Van Buuren Museum in Brussels, an architectural gem celebrated for its Art Deco design and exquisite landscaped gardens. The event offered members the opportunity to enjoy an evening surrounded by remarkable works of art, both inside the museum’s intimate rooms and in its serene outdoor spaces.
Despite the unusual summer heat, the dinner once again fulfilled its role as one of the association’s most valued networking opportunities, allowing members and guests to connect in a relaxed yet elegant setting ahead of the Annual General Assembly the following day. The evening featured not only fine cuisine, but also a classical chamber concert. The combination of beautiful surroundings, exceptional music, and engaging conversation made this gathering a highlight of the year.
Seasonal Connects
Planning ahead
Association / Networking / Working Groups
The 2025 Member Survey highlighted the need for more physical meetings, networking opportunities, events, and regular updates on Working Group activities. Feedback also confirmed that physical Working Group meetings are far more productive, with the pre-COVID rhythm of two per year proving particularly effective.
To address these needs, the General Assembly approved the introduction of three “Seasonal Connects”—Winter, Spring, and Autumn—planned well in advance. This new format will allow for at least 14 physical meetings per year, while requiring only seven days of activity in total, alongside two General Assemblies (one physical, one hybrid). The approach reduces costs for both Members and Nuclear Medicine Europe, streamlines administration, supports long-term planning, and drastically increases networking opportunities. Locations can also vary when planned ahead, ensuring flexibility and inclusivity.
Implementation begins in November 2025 with the inaugural Autumn Connect, marking a renewed commitment to fostering collaboration, engagement, and productive exchanges across the network.
The 2025 - 2028 Executive Committee
A New Mandate
Association / Executive Committee
The 2025–2028 Executive Committee of Nuclear Medicine Europe was elected during the Annual General Assembly held in Brussels.
Mart-Jan Blauwhoff (Curium Pharma), is elected President for the new three-year term. “The most important reason motivating my application today is that I want to actively support the ongoing projects and efforts that lie ahead of us, to continue of what has already been initiated, with the works and initiatives undertaken in recent months, particularly regarding the economic and geopolitical situation our industry is currently facing. For the near future of our association itself I would like us to become more international, whilst being bound by the rules and regulations of an EU (EEIG) organisation. I am convinced that NMEU can continue to play an important role to deal with the global challenges of our business,” said Mart-Jan Blauwhoff.
Dr. Konrade von Bremen (SWAN Isotopen AG), is elected Vice-President, Treasurer, and EU Affairs Delegate for the new three-year term. “Beyond my involvement in European affairs in general, I wish to place my motivation, my resilient commitment, and my enthusiasm at the service of a unique association grouping all industries dedicated to Nuclear Medicine which is on the brink to be recognised as a vital force in the present and future of medicine in Europe” said Konrade’.
Erich Kollegger (IRE – Institute for radioelements), is elected Secretary General for the new thre-year term. “I believe it is essential to continue fulfilling my responsibilities as supervisor of the SoS group, given the changes that will arise in the WG leadership over the next three years. And this, while also ensuring my availability for the role of Secretary General of our association” said Erich.
Etienne Boquien (GE HealthCare) is elected vice-President for the new three-year term. “Representative of GE Healthcare and already actively involved in the Communication Working Group for several years, I want to demonstrate my ongoing commitment to Nuclear Medicine Europe’s collaborative efforts and bring my multicultural perspective and a collaborative leadership style that aligns with Nuclear Medicine Europe’s pan European vision,” said Etienne.
Matt Morrison (Blue Earth Diagnostics) is elected vice-President for the new three-year term. “With over 25 years of experience in nuclear medicine, member of NMEU since 2018, I am confident that my skills and dedication align perfectly with Nuclear Medicine Europe main objectives and mission. I am eager to contribute to the Executive Committee’s efforts in
collaborating with a diverse group of professionals to achieve meaningful advancements,” said Matt.
The Nuclear Medicine Europe Executive Committee will serve as the unified voice of the nuclear medicine industry in Europe throughout this new three-year term. Stay tuned for the upcoming release of their strategic management plan, which will be announced shortly
